This page uses content from Wikipedia and is licensed under CC BY-SA.

Lacidipine

Lacidipine
Lacidipine structure.svg
Clinical data
Trade namesLacipil, Motens
AHFS/Drugs.comInternational Drug Names
Routes of
administration
Oral
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
Pharmacokinetic data
Bioavailability~10%
Protein binding>95%
MetabolismHepatic
Onset of action30–50 min
Elimination half-life13–19 hours
ExcretionFeces (~70%)
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
CompTox Dashboard (EPA)
ECHA InfoCard100.166.373 Edit this at Wikidata
Chemical and physical data
FormulaC26H33NO6
Molar mass455.543 g/mol g·mol−1
3D model (JSmol)
  (verify)

Lacidipine (tradenames Lacipil or Motens) is a calcium channel blocker. It is available as tablets containing 2 or 4 mg.

It was patented in 1984 and approved for medical use in 1991.[1]

References

  1. ^ Fischer, Jnos; Ganellin, C. Robin (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 466. ISBN 9783527607495.

External links